Innocan Pharma Provides its Annual “State of Research and Development” Update for 2024
HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical technology company focusing on developing…